This inventor holds 1 USPTO granted patent. Top assignee: Sungkyunkwan University. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Jong Sung Park: Innovator in Brain Disease Treatment
Introduction
Jong Sung Park is a notable inventor based in Bucheon-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of degenerative brain diseases. His innovative work has the potential to impact many lives.
Latest Patents
Jong Sung Park holds a patent for a composition aimed at preventing or treating degenerative brain diseases. This patent includes a pharmaceutical composition, a health functional food composition, and a method for addressing brain diseases or diabetes. The active ingredients in his formulation include chlorhexidine, thioguanosine, mebendazole, and several other compounds that target the expression of BACE1 proteins. He has 1 patent to his name.
Career Highlights
Park is affiliated with Sungkyunkwan University, where he conducts research and develops innovative solutions for health-related issues. His work is characterized by a commitment to advancing medical science and improving patient outcomes.
Collaborations
He collaborates with esteemed colleagues such as Dong Gyu Jo and Youngkwang Youn, contributing to a dynamic research environment that fosters innovation.
Conclusion
Jong Sung Park is a dedicated inventor whose work in the pharmaceutical field holds promise for the treatment of degenerative brain diseases. His contributions reflect a commitment to scientific advancement and the betterment of health care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile